Absorption |
Blood-Brain Barrier | BBB+ | 0.9810 |
Human Intestinal Absorption | HIA+ | 0.9937 |
Caco-2 Permeability | Caco2+ | 0.7897 |
P-glycoprotein Substrate | Substrate | 0.7069 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.6999 |
Non-inhibitor | 0.9594 |
Renal Organic Cation Transporter | Inhibitor | 0.6428 |
Distribution |
Subcellular localization | Lysosome | 0.5341 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8378 |
CYP450 2D6 Substrate | Substrate | 0.5212 |
CYP450 3A4 Substrate | Substrate | 0.6502 |
CYP450 1A2 Inhibitor | Inhibitor | 0.9107 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9081 |
CYP450 2D6 Inhibitor | Inhibitor | 0.8931 |
CYP450 2C19 Inhibitor | Inhibitor | 0.8993 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7379 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8129 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.6267 |
Non-inhibitor | 0.8853 |
AMES Toxicity | AMES toxic | 0.7050 |
Carcinogens | Non-carcinogens | 0.9428 |
Fish Toxicity | High FHMT | 0.9735 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9329 |
Honey Bee Toxicity | Low HBT | 0.6332 |
Biodegradation | Ready biodegradable | 0.5468 |
Acute Oral Toxicity | III | 0.7503 |
Carcinogenicity (Three-class) | Non-required | 0.5416 |